These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24907065)

  • 21. Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study.
    Tzelepis GE; Kelekis NL; Plastiras SC; Mitseas P; Economopoulos N; Kampolis C; Gialafos EJ; Moyssakis I; Moutsopoulos HM
    Arthritis Rheum; 2007 Nov; 56(11):3827-36. PubMed ID: 17968945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial fibrosis detected by magnetic resonance imaging, elevated U-CRP and higher mRSS are predictors of cardiovascular complications in systemic sclerosis (SSc) patients.
    Rodríguez-Reyna TS; Rosales-Uvera SG; Kimura-Hayama E; Hernández-Reyes P; Mercado-Velázquez P; Benavides-Suárez SA; Esquinca-González A; Núñez-Álvarez CA
    Semin Arthritis Rheum; 2019 Oct; 49(2):273-278. PubMed ID: 30853116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary fibrosis in systemic sclerosis: association with myocardial fibrosis.
    Nicholson PJ; Hegarty C; Jackson M; Keane D; Fitzgerald O; Bresnihan B; Veale D; Dodd JD
    J Thorac Imaging; 2012 Jan; 27(1):44-50. PubMed ID: 21107283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac magnetic resonance imaging with pharmacological stress perfusion and delayed enhancement in asymptomatic patients with systemic sclerosis.
    Kobayashi H; Yokoe I; Hirano M; Nakamura T; Nakajima Y; Fontaine KR; Giles JT; Kobayashi Y
    J Rheumatol; 2009 Jan; 36(1):106-12. PubMed ID: 19040307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The presence of abnormal septal motion on echocardiography is a predictor of abnormal cardiac magnetic resonance in systemic sclerosis.
    Javady-Nejad Z; Jamshidi AR; Aletaha A; Qorbani M; Kavosi H; Soltani A; Gharibdoost F
    Rheumatology (Oxford); 2024 Feb; 63(2):482-489. PubMed ID: 37216899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heart involvement in systemic sclerosis: an ultrasonic tissue characterisation study.
    Ferri C; Di Bello V; Martini A; Giorgi D; Storino FA; Bianchi M; Bertini A; Paterni M; Giusti C; Pasero G
    Ann Rheum Dis; 1998 May; 57(5):296-302. PubMed ID: 9741314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary myocardial dysfunction in autosomal dominant EDMD. A tissue doppler and cardiovascular magnetic resonance study.
    Smith GC; Kinali M; Prasad SK; Bonne G; Muntoni F; Pennell DJ; Nihoyannopoulos P
    J Cardiovasc Magn Reson; 2006; 8(5):723-30. PubMed ID: 16891232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of myocardial fibrosis in systemic sclerosis by contrast-enhanced magnetic resonance imaging.
    Nassenstein K; Breuckmann F; Huger M; Ladd SC; Schlosser T; Kreuter A; Barkhausen J
    Rofo; 2008 Dec; 180(12):1054-60. PubMed ID: 19009498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myocardial involvement in systemic sclerosis.
    Belloli L; Carlo-Stella N; Ciocia G; Chiti A; Massarotti M; Marasini B
    Rheumatology (Oxford); 2008 Jul; 47(7):1070-2. PubMed ID: 18503091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late Gadolinium Enhancement in Cardiac Magnetic Resonance Imaging Is Associated with High Renal Resistive Index in Patients with Systemic Sclerosis.
    Cianci R; Gigante A; Gasperini ML; Barbano B; Galea N; Rosato E
    Kidney Blood Press Res; 2020; 45(2):350-356. PubMed ID: 32101875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocardial fibrosis detected by magnetic resonance in systemic sclerosis patients - Relationship with biochemical and echocardiography parameters.
    Hromádka M; Seidlerová J; Suchý D; Rajdl D; Lhotský J; Ludvík J; Rokyta R; Baxa J
    Int J Cardiol; 2017 Dec; 249():448-453. PubMed ID: 28935460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T1 mapping cardiac magnetic resonance imaging frequently detects subclinical diffuse myocardial fibrosis in systemic sclerosis patients.
    Poindron V; Chatelus E; Canuet M; Gottenberg JE; Arnaud L; Gangi A; Gavand PE; Guffroy A; Korganow AS; Germain P; Sibilia J; El Ghannudi S; Martin T
    Semin Arthritis Rheum; 2020 Feb; 50(1):128-134. PubMed ID: 31301817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac magnetic resonance imaging before and after therapeutic interventions for systemic sclerosis-associated myocarditis.
    Panopoulos S; Mavrogeni S; Vlachopoulos C; Sfikakis PP
    Rheumatology (Oxford); 2023 Apr; 62(4):1535-1542. PubMed ID: 36083014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cardiopathy in systemic sclerosis].
    Valentini G; Maione S
    Recenti Prog Med; 1996 Nov; 87(11):557-63. PubMed ID: 9122540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations of right ventricular myocardial function with skin and pulmonary involvement in asymptomatic patients with systemic sclerosis.
    D'Andrea A; Bellissimo S; Scotto di Uccio F; Vigorito F; Moscato F; Tozzi N; Di Donato M; Citro R; Stisi S; Scherillo M
    Ital Heart J; 2004 Nov; 5(11):831-9. PubMed ID: 15633438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Noninvasive assessment of myocardial involvement in patients with systemic sclerosis: role of signal averaged electrocardiography.
    Morelli S; Sgreccia A; De Marzio P; Perrone C; Ferrante L; Gurgo AM; Gurgo di Castelmenardo AM; Aguglia G; De Vincentiis G; Scopinaro F; Calvieri S
    J Rheumatol; 1997 Dec; 24(12):2358-63. PubMed ID: 9415642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-invasive diagnostic and functional evaluation of cardiac and pulmonary involvement in systemic sclerosis.
    Sergiacomi G; De Nardo D; Capria A; Manenti G; Fabiano S; Borzi M; De Sanctis G; Konda D; Sperandio M; Schillaci O; Masala S; Simonetti G; Fontana L
    In Vivo; 2004; 18(2):229-35. PubMed ID: 15113051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Application of cardiac magnetic resonance imaging in subclinical systemic sclerosis primary heart involvement].
    Zhao Z; Zhao YN; Jin JY; Yang JS; Zhu J; Li T
    Zhonghua Nei Ke Za Zhi; 2024 Feb; 63(2):176-182. PubMed ID: 38326044
    [No Abstract]   [Full Text] [Related]  

  • 39. Primary myocardial involvement in systemic sclerosis.
    Kahan A; Allanore Y
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 4():iv14-7. PubMed ID: 16980717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imaging Patterns of Cardiovascular Involvement in Mixed Connective Tissue Disease Evaluated by Cardiovascular Magnetic Resonance.
    Mavrogeni S; Sfikakis PP; Dimitroulas T; Koutsogeorgopoulou L; Karabela G; Katsifis G; Stavropoulos E; Gialafos E; Spiliotis G; Kolovou G; Kitas GD
    Inflamm Allergy Drug Targets; 2015; 14(2):111-6. PubMed ID: 26728774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.